silver nanoparticles functionalized gel: physico- …
TRANSCRIPT
www.wjpps.com Vol 7, Issue 2, 2018.
76
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
SILVER NANOPARTICLES FUNCTIONALIZED GEL: PHYSICO-
CHEMICAL PROPERTIES AND ANTIBACTERIAL ACTIVITY
AGAINST ESCHERICHIA COLI, PSEUDOMONAS AERUGINOSA
AND STAPHYLOCOCCUS AUREUS
Eduardo José Jucá Mallmann1, Samuel Veloso Carneiro
1, Francisco Afrânio Cunha
1,3,
Maria Conceição Dos Santos Oliveira Cunha2, Everardo Albuquerque Menezes
3,
Tamara Gonçalves-Araújo4
and Pierre Basílio Almeida Fechine1*
1Grupo de Química de Materiais Avançados (GQMat)- Departamento de Química Analítica e
Físico-Química, Universidade Federal do Ceará – UFC, Campus do Pici, CP 12100, CEP
60451-970 Fortaleza – CE, Brazil. 2Mestranda da Universidade UNILAB- Universidade da Integração Internacional da Lusofonia
Afro-Brasileira, Fortaleza – CE, Brasil. 3Laboratório de Microbiologia da Faculdade de Farmácia, Odontologia e Enfermagem,
Universidade Federal do Ceará. 4Faculdade de Farmácia, Odontologia e Enfermagem, Universidade Federal do Ceará.
ABSTRACT
This study was performed to verify the stability, physicochemical
properties and antibacterial activity of a carbomer based gel
functionalized with silver nanoparticles (AgNPs) obtained by green
synthesis. Three formulations of Gel-AgNP were done: 0.5, 1.0 and
2.0% of AgNPs. The gel is skin-compatible and had shown interesting
rheological properties, assuming a pseudoplastic profile. In addition,
the stability of the gel was obtained and it was extremely satisfactory
for six months. The antibacterial activity was performed against
Escherichia coli, Pseudomonas aeruginosa and Staphylococcus
aureus, showing satisfactory results for 1.0 and 2.0% AgNPs gels
trough well-diffusion technique. The AgNPs gel could provide an
alternative to conventional antibacterial formulations (topical use) for
veterinary or human applications.
KEYWORDS: Silver nanoparticles; Carbomer gel; Green synthesis;
Antibacterial activity.
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
SJIF Impact Factor 6.647
Volume 7, Issue 1, 76-93 Research Article ISSN 2278 – 4357
*Corresponding Author
Pierre Basílio Almeida
Fechine
Grupo de Química de
Materiais Avançados
(GQMat)- Departamento de
Química Analítica e Físico-
Química, Universidade
Federal do Ceará – UFC,
Campus do Pici, CP 12100,
CEP 60451-970 Fortaleza –
CE, Brazil.
Article Received on
29 November 2017,
Revised on 19 Dec. 2017,
Accepted on 09 Jan. 2017
DOI: 10.20959/wjpps20182-10686
www.wjpps.com Vol 7, Issue 2, 2018.
77
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
INTRODUCTION
Some of recurrent employment of silver nanoparticles (AgNPs) are in paint with antibacterial
properties[1]
, wound dressing, also with anti-inflammatory and antimicrobial properties[2-4]
,
cosmetic industries[5]
and large use as growth controlling antimicrobial.[6-11]
Due to the
emergency and the raising of multi-resistant microorganisms, many researchers have been
studied a viable alternative in treatment of patients infected by those pathogens. Once the
new antibiotics demand a lot of time and money to be developed, and still there is the risk of
the inefficacy of them, even if they are newly released, because the microorganism may
previously develop resistance to them.[12,13]
Antiseptics silver-based have been largely
employed due to its large spectrum of activity against microorganisms and low resistance-
inducing of them, when compared to antibiotics.[14]
Among metallic nanoparticles, the silver are the ones that show the best bacteriostatic and
bactericide effects.[30]
The activity of silver salts against bacteria has been reported since the
old ages[15]
and the silver is used, nowadays, to control the growth of bacteria in a large scale
of applications, such as dental works, catheters and burns.[16,17]
Silver ions and compounds
containing silver are, actually, extremely toxic to microorganisms, showing biocides effects
in lot of bacteria.[18]
Aymonier and co-workers[19]
published a work showing functionalized
AgNPs with amphiphilic macromolecules associated to antimicrobials as capping agents. The
silver nanoparticles (AgNPs) show more intensive activity against microorganisms when
compared to its ions and salts of silver.[20-23]
Beyond the activity against bacteria and viruses,
[18,24-26] these nanoparticles had been used also to treat immunologic and inflammatory
disorders. Due to these reasons, the research concerning silver nanoparticles had increased on
the last years.[27,28]
Other metallic nanoparticles (that show a high surface area and a
reasonable amount of atoms on its surface) are also targets of researches due to its unique
physic-chemical properties, such as catalytic activities, optic and electronic properties,
antimicrobial activity and magnetic properties.[29-31]
According the resistance of microorganism to currently available antibiotics, AgNPs show
themselves as a new and effective alternative to combat pathogens, once its use does not
induce the resistance on the germs, even its mechanisms are not elucidated yet. A viable
alternative would be using silver as synergic agent to the antibiotics, however, this alternative
needs more studies and data.[32,33]
www.wjpps.com Vol 7, Issue 2, 2018.
78
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
MATERIALS AND METHODS
Obtaining the gel
Carbomer 940 and sodium carboxymethylcellulose were purchased from Chemistry (São
Paulo, Brazil). Trietanolamine (TEA) was purchased from Basf (São Paulo, Brazil) and
propylene glycol from Mapric (São Paulo, Brazil). AgNPs were synthetized starting from
AgNO3 (Dinâmica- São Paulo) 5mM solutions. The reduction of Ag+ ions was performed by
1.0g of ribose (Sigma- Brazil), and 0.5g of sodium citrate (Dinâmica- São Paulo) was used as
stabilizer agent. The temperatures of synthesis were 50 °C, 80 °C and 100 °C during 10
minutes. The AgNPs functionalized gel was produced using the nanoparticles synthetized at
100 °C.
Definite amount of CMC and carbomer 940 were dissolved in deionized water and mixed
using Omni Mixer Homogenizer (Model M50). It was added propylene glycol after 30 min of
stirring. This mixture was agitated for additional 10 min. The dispersion was then allowed to
hydrate and swell for 60 min and the pH of the neutralized sample was measured. The
Carbopol dispersion was neutralized with 98% TEA until the desired pH value of 6.0. During
neutralization, the mixture was stirred gently with a spatula until homogeneous gel was
formed. AgNPs were added in two different concentrations (1.0% and 2.0% w/w). These gel
formulations, were packaged under sterile conditions, labeled with appropriate details and
stored at room temperature for further uses. This last procedure is illustrated at Fig. 1.
Figure 1: Obtaining the gel functionalized with silver nanoparticles: (a) production of
AgNPs; (b, c) purification; (d) concentration, (e) production of gel and (f) gel.
www.wjpps.com Vol 7, Issue 2, 2018.
79
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
2.2. Antibacterial activity
Gel silver nanoparticles (Gel-AgNP) in two different concentrations 1.0% and 2.0% w/w
were tested for antimicrobial activity as method suggested by Srinivasulu et al.[34]
using
various Gram-positive and Gram-negative bacteria by the agar well-diffusion method.
Approximately, 20 mL of nutrient agar medium was poured into sterilized petri-dishes. The
bacterial test organisms were grown in nutrient broth for 24 h. A 100 μL nutrient broth
culture of each bacterial organism (1 × 105 CFUmL
−1) was used to prepare bacterial lawns.
Agar wells of 8 mm diameter were prepared with the help of a sterilized stainless steel cork
borer. The wells were loaded with 60 μL of Ag nanoparticles gel, 60 μL of culture with gel
without AgNPs as a negative control, along with 60 μL of 30 μg mL−1
of 1.0% silver
sulfadiazine as a positive control. The plates were incubated at 37 °C for 24 h and then were
examined for the presence of zones of inhibition.
2.3. Stability Evaluation
The experimental protocol was based on the guideline “Stability testing: of existing active
substances and related finished products” (CPMP/QWP/122/02). Three batches of the
formulation were produced under similar conditions and were then stored at room
temperature (realtime, 25 ± 2°C / 60% ± 5% humidity ) for 6 months and submitted to
accelerated aging for 60 days (oven at 40±2°C / 75% ± 5% humidity). The stability of the
formulation was defined by samples analysis without significant changes in parameters
physico-chemical. The stability samples (n=3) were taken for analysis at the end of the
following time periods: 30, 60, 90 and 180 days.
2.4. Characterization
2.4.1. pH
The pH was controlled using a potentiometric method (pH meter Metrohm ® pH Meter 744,
glass electrode).
2.4.2. Rheology
The apparent viscosity and rheological profile were evaluated using a Brookfield R/S –CC+
rotational viscometer ® equipped with V3 40/20 spindle. In these rheological tests were
evaluated three different gels (0.5%, 1.0% and 2.0%), with only comparative purposes.
www.wjpps.com Vol 7, Issue 2, 2018.
80
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
2.4.3 – UV-Vis Spectroscopy
The silver nanoparticles were identified by UV-VIS spectroscopy through a GENESYS®
10S (Malvern Instruments Ltd- England), UV-Vis spectrophotometer. The absorption band
near 400nm is a characteristic pattern of silver nanoparticles.
2.4.4. XRD
A Rigaku (Tokyo, Japan) X-ray powder diffractometer operating on 40 kV/30 mA with a Cu-
KαI tube (λ= 1.54056 Å) was used to obtain the X-ray diffraction pattern of the silver
nanoparticles. The diffraction patterns were carried out using Bragg-Brentano geometry in
continuous mode with speed of 1°/min and step size of 0.02° (2θ) in the angular range 20–80°
(2θ).
2.4.5 – Scanning Electron Microscopy
The scanning electron microscopy (SEM) was performed at an INSPECT 50 SEM with
EDS/EBSD and lithography.
RESULTS
The all lots of gel were transparent, light brown, uniform in appearance and without smell.
The pH value of SNG was 5.8 ± 0.05 (n=6), which is a physiologically acceptable pH. Two
Tables (1 and 2) show the variation of pH along 6 months and 2 months, when the gels were
stored at 25°C/60°C and 40°C/75°C respectively.
Table 1: Physicochemical characteristics of 1.0% and 2.0% AgNP gel stored at 25ºC
/60%RH.
AgNP GEL 25ºC /60%RH
Months Color
Smell/Odor
Appearance
pH a,b
1% 2%
1% 2%
1% 2%
1% 2%
0 NC NC
NC NC
NC NC
5.8±0.4 5.8±0.6
1 NC NC
NC NC
NC NC
5.9±0.25 5.8±0.4
2 NC NC
NC NC
NC NC
5.7±0.1 5.8±0.4
3 NC NC
NC NC
NC NC
5.8±0.08 6.1±0.5
6 NC NC
NC NC
NC NC
6.0±0.3 6.1±0.8
a= Mean ± SD, n =3; b= statistically significant difference vs. time zero= p = 0.003; NC= Not
Change.
www.wjpps.com Vol 7, Issue 2, 2018.
81
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
Table 2: Physicochemical characteristics of 1.0% and 2.0% AgNP gel stored at 40ºC
/75%RH.
AgNP GEL 40ºC/75% RH
Months Color Smell/Odor Appearance pH a,b
0 NC NC NC 5.8±0.4
1 Dark Brown NC PPT 6.4±1.5
2 Dark Brown NC PPT 7.2±1.8
a= Mean ± SD, n =3; b= statistically significant difference vs. time zero, p = 0.003; NC= Not
Change.
The UV-Vis spectroscopy had shown as an excellent technique to characterize AgNPs. The
absorption bands of the three different methods of synthesis of AgNPs are shown in Fig. 2.
Figure 2. UV–VIS absorption spectra of AgNPs. AgRC01-50 °C, AgRC02-80 °C and
AgRC03-100 °C.
The samples were prepared to X-ray diffraction according shown at Fig. 3, where 1.0mL of
the silver nanoparticle solution was dried at plates of glass under a temperature of 60.
www.wjpps.com Vol 7, Issue 2, 2018.
82
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
°C.
Figure 3. XRD patterns of the AgNPs and diffraction peaks from JCPDS (04-0783) used
for identification and comparison. AgRC01-50 °C, AgRC02-80 °C and AgRC03-100 °C.
To verify the morphology of silver nanoparicles acquired, it was performed the scanning
electron microscopy technique. The obtained results for the chosen sample, AgRC03, are
shown at Figs. 4a, 4b and 4c respectively.
(a)
www.wjpps.com Vol 7, Issue 2, 2018.
83
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
(b)
(c)
Figure 4. SEM image of the AgRC-03at an amplification of (a) 100,000X; (b) 238,000X;
(c) size distribution histogram.
The evaluation of the stability of the gel containing silver nanoparticles ( 1 % and 2 % )
subjected to accelerated stability conditions exhibited respectable stability with respect to
concentration of silver nanoparticles , except 40 ºC / 75 % RH (Table 3). The other results are
plotted in Figs. 5a and 5b, respectively. The results are plotted at Figs. 5a and 5b,
respectively.
www.wjpps.com Vol 7, Issue 2, 2018.
84
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
Table 3: Chemical stability of AgNP gel (1.0 and 2.0%) during stability testing AgNP
content (%)a.
1.0% AgNP GEL 2.0% AgNP GEL
Months 25ºC /60%RH 40ºC/75% RH 25ºC /60%RH 40ºC/75% RH
0 100.2% 100.2% 100.3 100.3
1 99.8±0,2 96 ±0,8 99.2±0.08 93 ±1,5
2 99.5±0,5 94.2± 1.5 98.7±0.2 90.1± 1.1
3 98.9±0.1 96.4± 0.9 97.5±0.1 87.8± 0.5
4 98.1±0.2
97.1±0.8
5 98.9±1.5
96.5±1.6
6 98.6±0,7 87.2± 1.2 95.6±0.5 82.7± 0.5b
a= Mean ± SD, n =3 b= statistically significant difference vs. time zero= p = 0.003.
(a)
(b)
Figure 5. Chemical stability of AgNP during the stability testing of gel (1 and 2%) at (a)
25°C; (b) 40°C.
www.wjpps.com Vol 7, Issue 2, 2018.
85
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
The results of rheological analyses are shown at Figs. 6a, 6b and 6c.The three samples (1, 2
and 3) had shown apparently mean viscosity as 1.8357 Pas, 3.6840 Pas and 3.3636 Pas
respectively.
(a)
(b)
(c)
Figure 6: Results rheological analysis: (a) Shear stress; (b) viscosity x deformation; (c)
viscosity x time.
www.wjpps.com Vol 7, Issue 2, 2018.
86
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
The Microbiological tests were as carried out in Petri dishes, checking the growth of colonies
of Escherichia coli in various gels as shown in Fig. 7.
Figure 7. (A) Antibacterial activity against Escherichia coli for gel without AgNP (1),
1.0% AgNP gel (2), 2.0% AgNP gel (3) and 1.0% silver sulfadiazine (4). (B) For gel
samples without AgNP (a), 1% AgNP gel (b) and 2% AgNP gel (c).
DISCUSSION
A large number of recent works demonstrates the antimicrobial activity of aqueous
suspensions of silver. From this perspective, one can develop topical gels with silver
nanoparticles, taking into consideration the properties of the product, which must conform to
the physiological features of human skin. It was observed that the formulations had
developed a pH between 5.7 and 6.1, which is ideal for use on human skin.
By UV-Vis spectroscopy, there was a band characteristic with wavelength of 420 nm called
plasmon band, which acts as fingerprints, for this type of product.[35-38]
The XRD
spectroscopy technique is complementary to UV -Vis, showing the formed phases of silver.
As verified at literature,[38-41]
the diffractogram is characteristic of silver (JCPDS-04-0793).
According the diffratogram shown in Fig. 3, it can be concluded the preferential growth of
the crystal is assigned to the plan (1 1 1). The geometry is face centered cubic (fcc).
As it can be seen, the nanoparticles show a spheric morphology as predominant geometry,
even that others types of particles are present, such as prismatic and as rod particles (Fig. 4b).
This results corroborates the literature[42-46]
that shows the predominance of spheric silver
nanoparticles when the plasmon bands are assigned to the region of 400 nm.
www.wjpps.com Vol 7, Issue 2, 2018.
87
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
About evaluation of the stability of the gels, it was found that AgNP test values for the
sample gel AgNP 1.0% stored at 25 °C / 60% RH was found to vary between 100.2 and 98.6
% after 12,3,4,5 and 6 months storage compared with the initial value of 100.9 % the
observed differences in assay values not statistically significant. The assay values were still
not significantly different. However, the assay values for the GSN samples stored at
40ºC/75% RH were 96 ±0,8, 94.2± 1.5, 96.4± 0.9 and 87.2± 1.5 after 1,2,3 and 6 moths,
respectively, indicating loss of SN after six months. For the 2.0% AgNP gel sample stored at
25ºC /60%RH were found to range between 100.0% and 95.6 after 1, 2, 3, 4, 5 and 6 months
of storage and compared to the initial value 100.3% the observed differences in assay values
not statistically significant. The assay values were still not significantly different. However,
the assay values for the Gel-AgNP samples stored at 40ºC/75% RH were 93 ±1,5, 90.1± 1.1,
87.8± 0.5 and 82.7± 0.5 after 1,2,3 and 6 months, respectively, indicating loss of AgNP after
six months.
The profiles observed in the rheological behavior can be understood by morphology and the
interaction between the gel and AgNP. Due to its high surface area per volume (AgNPs),
which show a high tendency to aggregate to minimize the total energy system, which
involves both attractive and repulsive forces.[47]
The surface charge may provide physical
stability to the system by preventing agglomeration of the nanoparticles through electrostatic
repulsion.[48]
Furthermore, these charges were exploited to improve the interaction between
nanoparticles and skin.[49,50]
According to the data obtained, these forces cause the change in
viscosity of the gel samples. All samples are characterized as pseudoplastic profile.
Pseudoplastic materials have an apparent viscosity decreased according as the shear rate
increases. It cannot be expressed by the number an isolated.[51]
The strain rate is also shear
function (shown in Fig. 6a).[52]
Observing the graphs, it appears that all gels showed a
distinction between the ascending and descending curves. This effect indicates that the fluid
is independent of time and hysteresis between the curves is indicative of a thixotropic
behavior.[53]
This profile is viable for high gels, because they deform during application,
which facilitates the spreading, but the viscosity returns to its original value when the process
is over. Thus, the product can not drain.[54]
The gel obtained in our study showed high activity against the bacteria E. coli (Figure 7). In a
previous study it was observed that the gel containing AgNPs may destroy the structure of
bacterial cell membranes in order to enter the bacterial cell. The AgNPs then condensed DNA
www.wjpps.com Vol 7, Issue 2, 2018.
88
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
and combined and coagulated with the cytoplasm of the damaged bacteria, resulting in the
leakage of the cytoplasmic component and the eventual death of the bacteria.[57]
Our gel was
activated in the minimum concentration of 1% AgNPs that proves the high antimicrobial
activity of AgNPs present in the cream and may represent a valuable ally in the treatment of
wounds.[58]
CONCLUSIONS
The gel functionalized with silver nanoparticles (1.0 and 2.0%) had shown effective action
against the strains of related bacteria on this work. These results sign for a further study,
investigating its activity at higher concentrations, for example. The physicochemical
properties had shown the skin compatibility (pH) of the formulations, nicer odor and color,
such as the rheological behavior is satisfactory. About the stability, the formulations had
shown a good profile for 25ºC/60ºC for six months.
ACKNOWLEDGMENTS
We gratefully acknowledge the financial support of Brazilian Agencies for Scientific and
Technological Development CNPq, CAPES and Funcap. Also, Projeto Central Analítica and
Laboratório de Raios-X from Universidade Federal do Ceará.
Conflicts of Interest
The authors declare no conflict of interest.
REFERENCES
1. Ataeefard M, Sharifi S. Antibacterial flexographic ink containing silver nanoparticles.
Prog Org Coat, 2014; 77: 118-123.
2. Jawal S, Dodoo CC, Walker M, Parsons D, Stapleton P, Beezer AE, Gaisford S. An in
vitro test of the efficacy of silver-containing wound dressings against Staphylococcus
aureus and Pseudomonas aeruginosa in simulated wound fluid. Int J Pharm, 2014; 462:
123-128.
3. Gaisford S, Beezer AE, Bishop AH, Walker M, Parsons D. An in vitro method for the
quantitative determination of the antimicrobial efficacy of silver-containing wound
dressings. Int J Pharm, 2009; 366: 111-116.
4. Hebeish A, El-Rafie MH, EL-Sheikh MA, Seleem AA, El-Naggar ME. Antimicrobial
wound dressing and anti-inflammatory efficacy of silver nanoparticles. Int J
BioMacromo, 2014; l65: 509-515.
www.wjpps.com Vol 7, Issue 2, 2018.
89
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
5. Sallum LF, Soares FLF, Ardila JA, Carneiro RL. Optimization of SERS scattering by Ag-
NPs-coated filter paper for quantification of nicotinamide in a cosmetic formulation.
Talanta, 2014; 118: 353-358.
6. Gu C, Zhang H, Lang M. Preparation of mono-dispersed silver nanoparticles assisted by
chitosan-g-poly (ɛ-caprolactone) micelles and their antimicrobial application. Appl Surf
Sci, 2014; 301: 273-279.
7. Mohan N, Oluwafemi OS, George SC, Jayachandran VP, Lewu, FB, Songca SP,
Kalarikkal N, Thomas S. Completely green synthesis of dextrose reduced silver
nanoparticles, its antimicrobial and sensing properties. Carbohyd Polym, 2014; 106: 469-
474.
8. Lokina S, Stephen A, Kaviyarasan V, Arulvasu C, Narayanan C. Cytotoxicity and
antimicrobial activities of green synthesized silver nanoparticles. Eur J Med Chem, 2014;
76: 256-263.
9. Rhim JW, Wang LF, Hong SI. Preparation and characterization of agar/silver
nanoparticles composite films with antimicrobial activity. Food Hydrocolloid, 2013; 33:
327-335.
10. Akhavan A, Sheikh N, Khoylou F, Naimian F, Ataeivarjovi E. Synthesis of antimicrobial
silver/hydroxyapatite nanocomposite by gamma irradiation. Radiat Phys and Chem, 2014;
98: 46-50.
11. Kanmani P, Rhim, JW. Physicochemical properties of gelatin/silver nanoparticle
antimicrobial composite films. Food Chem, 2014; 148: 162-169.
12. Rai M, Kon K, Ingle A, Duran N, Galdiero S, Galdiero M. Broad-spectrum bioactivities
of silver nanoparticles: the emerging trends and future prospects. Appl Microbiol
Biotechnol, 2014; 98: 1951–1961.
13. Nordmann P. Carbapenemase-producing Enterobacteriaceae: Overview of a major public
health challenge. Med Maladies Infect, 2014; 44: 51–56.
14. Jones SA, Bowler PG, Walker M, Parsons D. Controlling wound bioburden with a novel
silver-containing Hydrofiber dressing. Wound Repair Regen, 2004; 12: 288-294.
15. Silver S, Phung LT. Bacterial heavy metal resistance: new surprises. Annu Rev
Microbiol, 1996; 50: 753-789.
16. Catauro M, Raucci MG, De Gaetano, FD, Marotta A. Antibacterial and bioactive silver-
containing Na2OCaO2SiO2 glass prepared by sol-gel method. J Mater Sci Mater Med,
2004; 15: 831-837.
www.wjpps.com Vol 7, Issue 2, 2018.
90
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
17. Crabtree JH, Burchette RJ, Siddiqi RA, Huen IT, Handott LL, Fishman A. The efficacy of
silver-ion implanted catheters in reducing peritoneal dialysis-related infections. Perit Dial
Int, 2003; 23: 368-74.
18. Zhao G, Stevens Jr, SE. Multiple parameters for the comprehensive evaluation of the
susceptibility of Escherichia coli to the silver ion. Biometals, 1998; 11: 27-32.
19. Aymonier C, Schlotterbeck U, Antonietti L, Zacharias P, Thomann R, Tiller JC, Mecking
S. Hybrids of silver nanoparticles with amphiphilichy perbranched macromolecules
exhibiting antimicrobial properties. Chem Commun, 2002; 24: 3018-3019.
20. Ansari MA, Khan HM, Khan AA, Malik A, Sultan A, Shahid M, Shujatullah F, Azam A.
Evaluation of antibacterial activity of silver nanoparticles against MSSA and MSRA on
isolates from skin infections. Biol Med, 2011: 3: 141-146.
21. Gong P, Li H, He X, Wang K, Hu J, Tan WS, Zhang S, Yang X. Preparation and
antibacterial activity of Fe3O4-Ag nanoparticles. Nanotechnology, 2007; 18: 604-611.
22. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials.
Biotechnology Adv, 2009; 27: 76-83.
23. Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PK, Chiu JF, Che CM.
Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome
Res, 2006; 5: 916-924.
24. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang
CY, Kim K, Lee YS, Jeong DH, Cho MH. Antimicrobial effects of silver nanoparticles.
Nanomed Nanotechnol. Biol Med, 2007; 3: 95–101.
25. Magaña SM, Quintana P, Aguilar DH, Toledo JA, Ángeles-Chávez C, Cortés MA, León
L, Freile-Pelegrín Y, López T, Sánchez RMT. Antibacterial activity of montmorillonites
modified with silver. J Mol Catal A, 2008; 281: 192–199.
26. Shin SH, Ye MK, Kim HS, Kang HS. The effects of nano-silver on the proliferation and
cytokine expression by peripheral blood mononuclear cells. Int Immuno pharmacol, 2007;
7: 1813–1818.
27. Kim TN, Feng QL, Kim JO, Wu J, Wang H, Chen GC, Cui FZ. Antimicrobial effects of
metal ions (Ag+, Cu
2+, Zn
2+) in hydroxyapatite. J Mater Sci Mater Med, 1998; 9: 129-134.
28. Cho KH, Park JE, Osaka T, Park SG. The study of antimicrobial activity and preservative
effects of nanosilver ingredient. Electrochim Acta, 2005; 51: 956-960.
29. Kowshik M, Ashtaputre S, Kharrazi S. Extracellular synthesis of silver nanoparticles by a
silver-tolerant yeast strain MKY3. Nanotechnology, 2003; 14: 95-100.
www.wjpps.com Vol 7, Issue 2, 2018.
91
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
30. Souza GI, Marcato PD, Duran N, Esposito E. Utilization of Fusarium oxysporum in the
biosynthesis of silver nanoparticles and its antibacterial activities. In: Xth National
Meeting of Environmental Microbiology, Curitiba, Brazil, 2004.
31. Duran N, Marcato PD, Alves OL, Souza G, Esposito E. Mechanistic aspects of
biosynthesis of silver nanoparticles by several Fusarium oxysporum strains. J
Nanotechnology, 2005; 3: 8.
32. Wright GD. Resisting resistance: new chemical strategies for battling superbugs. Chem
Biol, 2007; 7: 127-132.
33. Wright GD. Bacterial resistance to antibiotics: enzymatic degradation and modification.
Adv Drug Deliv Rev, 2005; 57: 1451-1470.
34. Srinivasulu B, Prakasham RS, Jetty A, Srinivas S, Ellaiah P, Ramakrishna SV. Neomycin
production with free and immobilized cells of Streptomyces marinensis in an airlift
reactor. Process Biochem, 2002; 38: 593-598.
35. Rastegarzadeh S, Hashemi F. A surface plasmon resonance sensing method for
determining captopril based on in situ formation of silver nanoparticles using ascorbic
acid. Spectrochim Acta A, 2014; 12: 536-541.
36. Liu P, Zhao L, Wu X, Huang F, Wang M, Liu X. Fluorescence enhancement of quercetin
complexes by silver nanoparticles and its analytical application. Spectrochim Acta A,
2014; 122: 238-245.
37. Chhatre A, Solasa P, Sakle S, Thaokar R, Mehra A. Color and surface plasmon effects in
nanoparticle systems: Case of silver nanoparticles prepared by microemulsion route.
Colloid Surface A, 2012; 404: 83-92.
38. Bindhu MR, Umadevi M. Surface plasmon resonance optical sensor and antibacterial
activities of biosynthesized silver nanoparticles. Spectrochim Acta A, 2014; 121: 596-
604.
39. Kumar DA, Palanichamy V, Roopan SM. Green synthesis of silver nanoparticles using
Alternanthera dentata leaf extract at room temperature and their antimicrobial activity.
Spectrochim Acta A, 2014; 127: 168-171.
40. Ahluwalia V, Kumar J, Sisodia R, Shakil NA, Walia S. Green synthesis of silver
nanoparticles by Trichoderma harzianum and their bio-efficacy evaluation against
Staphylococcus aureus and Klebsiella pneumonia. Ind Crop Prod, 2014; 55: 202-206.
41. Gade A, Gaikwad S, Duran N. Rai M. Green synthesis of silver nanoparticles by Phoma
glomerata. Micron, 2014; 59: 52-59.
www.wjpps.com Vol 7, Issue 2, 2018.
92
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
42. Olenin AY, Krutyakov YA, Kundriskii AA, Lisichkin GV. Formation of surface layers on
silver nanoparticles in aqueous and water-organic media. Colloid J, 2008; 70: 71-72.
43. Lima IO, Oliveira RAG, Lima EO, Farias NMP, Souza EL. Atividade antifúngica de
óleos essenciais sobre espécies de Candida. Braz J Pharmacog, 2006; 6: 197-201.
44. Araujo JCLV, Lima EO, Ceballos BSO, Freire KRL, Souza EL, Filho LS. Ação
antimicrobiana de óleos essenciais sobre microrganismos potencialmente causadores de
infecções oportunistas. Rev Patol Trop, 2004; 33: 55-64.
45. Trombin AC. Avaliação de atividade bactericida de nanopartículas de prata e ouro
impregnadas com antimicrobiano. Universidade do Extremo Sul Catarinense, Criciúma,
2010.
46. Arendrup MC. Epidemiology of invasive candidiasis. Cur Opin Crit Care, 2010; 6: 445-
452.
47. Raj S, Jose S, Sumod US, Sabitha M. Nanotechnology in cosmetics: opportunities and
challenges. J Pharm Bioallied Sci, 2012; 4: 186-193.
48. Freitas C, Müller RH. Effect of light and temperature on zeta potential and physical
stability in solid lipid nanoparticle (sln™) dispersions. Int J Pharm, 1998; 168: 221-229.
49. Peira E, Carlotti ME, Trotta C, Cavalli R, Trotta M. Positively charged microemulsions
for topical application. Int JPharm, 2008; 346: 119-123.
50. Ridolf DM, Marcato PD, Justo GZ, Cordi L, Machado D, Duran N. Chitosan-solid lipid
nanoparticles as carriers for topical delivery of tretinoin. Colloid Surfaces B, 2012; 93:
36-40.
51. Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. Silver nanoparticles
in therapeutics: development of an antimicrobial gel formulation for topical use. Mol
Pharm, 2009; 6: 1388-1401.
52. Aulton M. Delineamento de formas farmacêuticas. 2nd ed. Artmed: Brasil, 2005.
53. Soriano MMJ, Contreras MJF, Flores ES. Proposaland pharmacotechnicall study of a
modern dermopharmaceutical formulation for cold cream. Boll ChimFarm, 1996; 135:
364-373.
54. Jiang J, Oberdorster, G, Biswas, P. Characterization of size, surface charge, and
agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res,
2009; 11: 77-89.
55. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the
antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J
Biomed Mater Res, 2000; 52: 662-668.
www.wjpps.com Vol 7, Issue 2, 2018.
93
Almeida et al. World Journal of Pharmacy and Pharmaceutical Sciences
56. Duran N, Marcart, PD, De Souza GIH, Alves OL, Esposito E. Antibacterial effect of
silver nanoparticles produced by fungal process on textile fabrics and their effluent
treatment. J Biomed Nanotechnol, 2007; 3: 203–208.
57. Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. Silver
Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for
Topical Use. Molecular Pharmaceutics, 2009; 6: 1388–1401.
58. Chen M, Yang Z, Wu H, Pan X, Xie X, Wu C. Antimicrobial activity and the mechanism
of silver nanoparticle thermosensitive gel. International Journal of Nanomedicine, 2011;
6: 2873–2877.